Harbor Capital Advisors, Inc. Adma Biologics, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $1.29 Billion
- Q3 2025
A detailed history of Harbor Capital Advisors, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 59,801 shares of ADMA stock, worth $895,220. This represents 0.07% of its overall portfolio holdings.
Number of Shares
59,801Holding current value
$895,220% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
401Shares Held
196MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$320 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$279 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$192 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$181 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$88.5 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.94B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...